cyclohexanol has been researched along with Phobic Disorders in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 12 (54.55) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roy-Byrne, P | 1 |
| Hoge, EA; Keshaviah, A; Pollack, MH; Simon, NM; Stein, MB; Van Ameringen, M; Worthington, JW | 1 |
| Dalrymple, KL | 1 |
| Bandelow, B; Wedekind, D | 1 |
| Silberman, EK | 1 |
| Pollack, MH; Simon, N; Stein, M; Van Ameringen, M | 1 |
| Davis, ML; Hofmann, SG; Smits, JA | 1 |
| Mancini, C; Patterson, B; Simpson, W; Van Ameringen, M | 1 |
| Girardi, P; Kotzalidis, GD; Manfredi, G; Pacchiarotti, I; Ruberto, A; Tatarelli, R | 1 |
| Bystritsky, A; Kelsey, JE; Mangano, RM; Pollack, MH; Stein, MB | 1 |
| Allgulander, C; Dahl, AA; Emilien, G; Lepola, U; Mangano, R; Sjödin, I; Zhang, J | 1 |
| Khan, A; Mangano, R; Rickels, K | 1 |
| Gelenberg, AJ; Liebowitz, MR; Munjack, D | 1 |
| Asnis, G; Bradwejn, J; Liebowitz, MR; Mangano, RM | 1 |
| Dervaux, A | 1 |
| Renneberg, B; Ströhle, A | 1 |
| Cottraux, J | 1 |
| Kelsey, JE | 1 |
| Benazzi, F | 1 |
| Altamura, AC; Mannu, P; Pioli, R; Vitto, M | 1 |
| Ninan, PT | 1 |
| Durkin, JP | 1 |
4 review(s) available for cyclohexanol and Phobic Disorders
| Article | Year |
|---|---|
Update on the efficacy of pharmacotherapy for social anxiety disorder: a meta-analysis.
Topics: Antidepressive Agents; Antipsychotic Agents; Cyclohexanols; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Phenelzine; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Pharmacotherapy for social anxiety disorder: an update.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Drug Resistance; Humans; Monoamine Oxidase Inhibitors; Phobic Disorders; Psychotropic Drugs; Randomized Controlled Trials as Topic; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
[Psychotherapies: what is the impact on the cortical and subcortical levels?].
Topics: Brain; Cyclohexanols; Depression; Humans; Obsessive-Compulsive Disorder; Phobic Disorders; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Use of venlafaxine in other psychiatric disorders.
Topics: Anxiety; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fibromyalgia; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Trichotillomania; Venlafaxine Hydrochloride | 2000 |
8 trial(s) available for cyclohexanol and Phobic Disorders
| Article | Year |
|---|---|
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phobic Disorders; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.
Topics: Adult; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Outpatients; Patient Dropouts; Phobic Disorders; Psychiatric Status Rating Scales; Reproducibility of Results; Single-Blind Method; Suicide; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety Disorders; Control Groups; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Phobic Disorders; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Social Behavior; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Paroxetine; Phobic Disorders; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Analysis of Variance; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Phobic Disorders; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Venlafaxine in social phobia.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Male; Middle Aged; Phobic Disorders; Psychiatric Status Rating Scales; Retrospective Studies; Venlafaxine Hydrochloride | 1995 |
Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders.
Topics: Adolescent; Cyclohexanols; Female; Humans; Male; Personality Disorders; Phobic Disorders; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
10 other study(ies) available for cyclohexanol and Phobic Disorders
| Article | Year |
|---|---|
Treatment in nonresponsive patients with social anxiety: back to the future with benzodiazepines.
Topics: Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Female; Humans; Male; Phobic Disorders; Sertraline; Venlafaxine Hydrochloride | 2014 |
Longer term outcomes need to be examined for enhancing the treatment of social anxiety disorder after insufficient improvement with sertraline.
Topics: Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Female; Humans; Male; Phobic Disorders; Sertraline | 2014 |
[Social phobia].
Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Cyclohexanols; Evidence-Based Medicine; Humans; Phobic Disorders; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
The role of benzodiazepines in treating social anxiety disorder.
Topics: Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Female; Humans; Male; Phobic Disorders; Sertraline | 2014 |
Response to Silberman.
Topics: Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Female; Humans; Male; Phobic Disorders; Sertraline | 2014 |
A case of social phobia and avoidant personality disorder with erectile dysfunction successfully treated with venlafaxine and add-on reboxetine.
Topics: Adult; Cyclohexanols; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Morpholines; Personality Disorders; Phobic Disorders; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
[Cannabis dependence and social phobia].
Topics: Adult; Cyclohexanols; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Paroxetine; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
[Social anxiety disorders].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Evidence-Based Medicine; Humans; Personality Disorders; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Venlafaxine withdrawal symptoms.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Dysthymic Disorder; Humans; Male; Phobic Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1996 |
Gabapentin in complicated school refusal.
Topics: Acetates; Adolescent; Amines; Comorbidity; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyzine; Male; Mental Disorders; Phobic Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |